Partial nerve injury is the main cause of neuropathic pain disorders in humans. Acupuncture has long been used to relieve pain. It is known to relieve pain by controlling the activities of the autonomic nervous system. Although the mechanism of neuropathic pain and analgesic effects of electroacupuncture (EA) have been studied in a rat model system, its detailed mechanism at the molecular level remains unclear. To identify genes that might serve as either markers or explain these distinct biological functions, a cDNA microarray analysis was used to compare the expression of 8,400 genes among three sample groups. Messenger RNAs that were pooled from the spinal nerves of 7 normal, 7 neuropathic pain, and 7 EA treatment rat models were compared. Sixty-eight genes were differentially expressed more than 2-fold in the neuropathic rat model when compared to the normal, and restored to the normal expression level after the EA treatment. These genes are involved in a number of biological processes, including the signal transduction, gene expression, and nociceptive pathways. Confirmation of the differential gene expression was performed by a dotblot analysis. Dot-blotting results showed that the opioid receptor sigma was among those genes. This indicates that opioid-signaling events are involved in neuropathic pain and the analgesic effects of EA. The potential application of these data include the identification and characterization of signaling pathways that are involved in the EA treatment, studies on the role of the opioid receptor in neuropathic pain, and further exploration on the role of selected identified genes in animal models.
Introduction
Neuropathic pain is part of the neurological disease spectrum and may be an expression of severe medical pathology (Hansson, 2002) . Partial nerve injury is the main cause of neuropathic pain disorders in humans. The pain is characterized by a spontaneous burning pain that is accompanied by hyperalgesia and allodynia that lasts variable time spans (Talmoush, 1981) . As already observed, this pain is often unresponsive to analgesics. Acupuncture has long been used to relieve pain. It is known to relieve pain by controlling the activities of the autonomic nervous system (Kimura and Sato, 1997) . The descending inhibitory system and endogenous opioid (<biblio>) mediate this pain relief function of acupuncture (Han and Terenius, 1982) . It has also been proposed that acupuncture triggers diffuse noxious inhibitory control on convergent neurons at the medullary and spinal levels (Bing et al., 1990) .
Although the mechanism of neuropathic pain and analgesic effects of electroacupuncture (EA) have been studied in a rat model system, its detailed mechanism at the molecular level remains unclear. As a marker of neuronal activation of the central nervous system, the cellular fos (c-fos) expression has been widely used to monitor the change in neuronal activity that is evoked by peripheral input (Doucet et al., 1990; Ji et al. 1993; Guo et al., 1996) . C-fos proto-oncogene is an immediate early-response (IER) gene, which is characterized by the rapid, stimulus -mediated induction of the expression in neuronal and non-neuronal cells (Doucet et al., 1990; Bogoyevitch et al., 2001) . Besides IER genes, several opioid genes including preproenkephalin (PPE), preprodynorphine (PPD) and proopiomelanocortin (POMC) are expressed by the *To whom correspondence should be addressed. EA treatment (Lee and Beitz, 1992; Pan et al., 1994; Ji et al., 1993; Guo et al., 1996) . Although evidence from recent studies indicate that several genes are involved in neuronal activities, little information is available regarding the genes that are involved in the development of neuropathic pain and the analgesic effects of EA.
In the present study, we developed a neuropathic animal model that showed causalgic signs on the tail. We analyzed the genes that were expressed differentially in the neuropathic pain model and EA treatment model using cDNA miroarray.
Materials and Methods
Experimental animals Young adult male Sprague-Dawley rats (Sam : TacN(SD)BR, 200-220 g, n = 21) were housed in group cages (4-5 per cage) with water and food available ad libitum. The room was light/dark (08 : 00 -20 : 00 light, 20 : 00 -08 : 00 dark) controlled and kept at 21-24 o C. All of the experiments were conducted in accordance with the guidelines of the International Association for the Study of Pain.
Neuropathic surgery For neuropathic surgery, the rat-tail model was used, as described previously (Na et al., 1994; . Briefly, under sodium pentobarbital anesthesia (40 mg/kg, i.p.), the right superior caudal trunk was exposed and transected at the level between the S1 and S2 spinal nerves that innervated the rat tail. To prevent the possible rejoining of the proximal and distal ends of the severed trunk, about a 2 mm piece of the trunk was removed from the proximal end. This surgery eliminated the S1 spinal nerve innervation to the tail via the right superior caudal trunk.
Behavioral test of neuropathic pain
The mechanical allodynia was assessed by a normally innocuous stimulation of the tail with von Frey hair (bending force: 2.0 g). For a convenient application of stimuli with von Frey hair and acupuncture, the rat was restrained in a plastic holder (5.3 × 15, 6.3 × 18 cm in diameter × length), and the tail was laid on a plate. The mechanically-sensitive area was first determined by rubbing various areas of the tail with von Frey hair. The actual test was performed by gently poking the most sensitive spot with von Frey hair. An abrupt tail movement of more than 0.1 cm was considered an abnormal response that was attributed to mechanical allodynia. The stimulation was repeated 10 times at 10-sec intervals for each animal at each testing time or day. During the repeated trials, the test stimuli were delivered to the same spot with no difficulty, since the tail was usually stationary. The degree of response was expressed as a percentage of response frequency and was determined as follows;
Response Frequency (%) = number of abnormal responses × 100 10
EA stimulation Two stainless-steel needles of 0.25 mm diameter and 5 mm in length were inserted into Zusanli (ST36), which is located at the anterior tibial muscle and about 10 mm below the knee joint. This point produces an analgesic effect in the tail-flick response. For EA, train-pulses (2 Hz, 0.3-ms pulse width, 0.2-0.3 mA) were applied to the inserted needle for 30 min. The other needle (anode) was inserted into the anterior tibial muscle 5 mm that was distal to the first one. Anodal and cathodal leads from an electric stimulator were connected to the two acupuncture needles. Fig. 1 . Pain relief effect of EA treatment on mechanical allodynia. Three weeks after the neuropathic surgery, the control (n = 7) and EA treatment groups (n = 7) showed a high response frequency. The EA treatment group was given train-pulse (2 Hz, 0.3 ms pulse-width, 0.2-0.3 mA) for 30 min. In the EA treatment group, there were marked decreases in response frequency, whereas the control and normal sham-operation groups (n = 7) showed no significant changes. Asterisks indicate the values that were significantly different from the value before EA treatment (p<0.01 by the Friedman rank test followed by the Dunnett posthoc test). cDNA Microarray Analysis Gene Discovery Array Mouse version 1.1 (Incyte genomics, Palo Alto, CA) was used for a cDNA microarray analysis. It consisted of one 22 × 22 cm nylon filter that was spotted with 8,400 non-redundant mouse cDNA clones that was chosen from the I.M.A.G.E. collection. Total RNAs were isolated from the spinal cord using Trizol (Life Technologies, Gaithersburg, MD), followed by the isolation of mRNA using OligoTex (Qiagen, Valencia, CA). The cDNA preparation was labeled with [α-32 P]dCTP and hybridization was performed according to the manufacturers instruction. After hybridization, the filters were exposed to X-ray film and quantified by scanning densitometry.
Dot Blot Analysis
Total RNAs were isolated from the spinal cord using RNA Stat-60 (TEL-TEST, Inc., Friendswood, TX) according to the manufacturers instruction. Two µg of total RNA was denatured and dotted onto a Hybond N + nylon membrane (Amersham Pharmacia Biotech., Piscataway, NJ). Cross-linking was then performed using UV irradiation. The filters were prehybridized overnight at 42 o C in a Northern-Max hybridization solution (Ambion, Inc., Austin, TX). Hybridization was carried out overnight at 42 o C in the same solution that contained probes that were labeled with [α-32 P]dCTP (DuPont NEN, 6000 Ci/mmol) by the random primer method. The DNA probes were synthesized by a reverse transcriptase-polymerase chain reaction method using rat brain-derived mRNA as a template. The following probes were used in these experiments: (1) a 445-bp cDNA fragment corresponding to bases 777-1221 of the reported opioid receptor 
Fig. 2. Expression profile of normal (A), neuropathic pain (B)
, and EA treatment models (C). Spinal cord mRNA was obtained from a normal rat sample neuropathic pain model that was developed previously , and EA treatment sample that was stimulated with EA for 30 min a day for 2 days. The expression level intensity was determined using image analyzing software. Arrows indicate examples of the differentially-expressed genes. Data analysis Data were represented as means ± standard error. The significance of the statistical differences was determined using the Friedman rank test, followed by the Dunnett post-hoc test in a group. p < 0.05 was considered significant.
Results and Discussion
Pain relief effect of EA on mechanical allodynia Recently, several behavioral models for peripheral neuropathy that were produced in a rats tail were developed. We used a previously-developed rat model for neuropathic pain (Na et al., 1994; . The sign of mechanical allodynia appeared 1 day after surgery; maximal allodynia was observed in 2-3 weeks (Hwang et al., 2002) . Following this result, EA was applied three weeks after surgery. Behavioral tests of mechanical allodynia were performed before and during EA at 10-min interval. In the EA-treatment group (n = 7), there were marked decreases in the response frequency (90.014.1, 35.724.4, 27.118.0 and 15.728.8%, respectively). The Dunnett post-hoc test, after the Friedman rank test, indicated that there Fig. 3 . Genes involved in signal transduction are expressed differentially in the pain model and restored after EA treatment. Total RNAs (2 µg) were isolated from the spinal cord that was obtained from the normal (N), neuropathic pain (P), and EA treatment models (A). After the total RNAs were dotted on nylon filters, the blots were hybridized with 32 P-labeled probes. The probes that were used in the dot-blot analysis were opioid receptor sigma (A), MAP kinase 11 (B), APO-1/CD95 (Fas)-associated phosphatase (C), and LIM protein (D). GAPDH (E) total RNAs were used as a control.
were statistically significant differences at 10, 20, and 30 min from the initiation of EA. The maximal pain relief effect of EA on mechanical allodynia was shown at 30 min after the initiation of EA (Fig. 1). cDNA microarray analysis To identify genes that might either serve as markers or explain neuropathic pain development, or the analgesic effects of EA, a cDNA microarray analysis was used to compare the expression of 8,400 genes among three sample groups. Messenger RNAs were compared that were pooled from the spinal nerves of 7 normal, 7 neuropathic pain, and 7 EA treatment rat models. Eleven genes were identified as differentially-expressed genes between the normal and neuropathic pain models (Table 1) . Among these 11 genes, 5 genes increased and 6 genes decreased in the pain model. These genes were involved in the transcription, protein synthesis, and degradation process (data not shown). Table 2 shows that the gene numbers were expressed differentially between the neuropathic pain and EA treatment models. Among 45 genes, 8 genes increased and 37 genes decreased in the EA treatment rat model, compared to the neuropathic pain rat model. These genes include receptors, signaling molecules, protein kinases, and chaperonic proteins (data not shown).
Since acupuncture treatment is known to relieve neuropathic pain, we focused on the genes that were differentially expressed in the pain model when compared to the normal, and restored to the normal expression level after the EA treatment. As shown in Table 3 , 68 genes were differentially expressed more than 2-fold in the neuropathic rat model when compared to the normal, and restored to the normal expression level after the EA treatment. These genes are involved in a number of biological processes, including signal transduction, gene expression, and nociceptive pathway. The genes that were involved in the signal transduction pathway include the mitogen-activated protein (MAP) kinase (Kim et al.) , protein tyrosine phosphatase, protein kinase c binding protein, regulator protein of the G-protein signaling, and T cell receptor. The genes that were involved in the gene expression regulation include the zinc finger protein 6 and TATA-binding protein-binding protein. Interestingly, the opioid receptor sigma was one of those genes that was expressed differentially in the neuropathic pain model, and restored to the normal level after the EA treatment (Table 3) . However, one third of the genes that were identified were unknown genes, or functionally uncharacterized genes. Fig. 4 . The genes that were involved in the various biological processes are expressed differentially in the pain model and restored after EA treatment. Total RNAs (2 µg) were isolated from the spinal cord that was obtained from normal (N), neuropathic pain (P), and EA treatment models (A). After the total RNAs were dotted on nylon filters, the blots were hybridized with 32 P-labeled probes. The probes that were used in the dot-blot analysis were Nck-associated protein (A), iroquois homeobox protein 5 (B), tumor necrosis factor α-induced protein 6 (C), and diaphanous 2 (D). GAPDH (E) total RNAs were used as a control.
Opioid receptor is involved in analgesic process of EA Confirmation of the differential gene expression was performed by a dot-blot analysis. Among 68 genes that we considered, the mRNA expression level of 8 genes was downregulated in the neuropathic pain model when compared to the normal rat, and the mRNA expression level of these genes was restored to the normal state in the EA treatment sample. Results from dot blotting showed that the opioid receptor sigma was one of those genes, indicating that the opioid signaling event is involved in neuropathic pain and the analgesic effects of EA. The expression level of the opioid receptor sigma gene decreased about 50% in the neuropathic pain model. However, 1 day after the EA treatment, the mRNA expression level of the opioid receptor sigma was restored to its normal expression level. This result indicates that the cells in the spinal cord cannot normally transduce the signal in response to opioid stimulation since the opioid receptor is down-regulated in the neuropathic pain model. However, the EA treatment restores the expression level of the opioid receptor in response to the opioid signal that gives rise to analgesic effects. It was reported that endogenous opioids may be implicated in acupuncture analgesia (He, 1987) . For example, acupuncture produces an increase in the opioid-like immunoreactivity in the CSF of patients with chronic pain from different sources (Ho and Wen, 1989) . Our data suggest that the opioid receptor probably plays an important role in the development of neuropathic pain and the analgesic effects of EA.
Besides the opioid receptor, several interesting genes, such as the MAP kinase, zinc finger protein, and tyrosine phosphatase, were identified. The expression level of these genes decreased about 40-60% in the neuropathic pain model. However, 1 day after the EA treatment, the mRNA expression level of these genes was restored to the normal expression level. These genes are known to function on important signal transduction pathways and gene expressions. Therefore, multiple signaling pathways, including opioid receptor-and MAP kinase-mediated pathways, as well as other gene expressions, might be involved in the pain development and analgesic effects of EA.
While further studies are required in order to delineate the signaling pathways that lead to chronic neuropathic pain and pain relief by acupuncture, this is the first report that analyzes the genes that are expressed differentially in the neuropathic pain and EA treatment models. From this information, we can begin to understand the molecular mechanism of pain development and analgesic effects of acupuncture, which are important events in pathological processes. The potential application of these data include the identification and characterization of signaling pathways that are involved in acupuncture treatment, studies on the role of the opioid receptor in neuropathic pain, and further exploration on the role of selected identified genes in animal models.
